Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2017

  • ID: 4394260
  • Report
  • 150 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Axcelon Biopolymers Corp.
  • Coromedic Ltd.
  • Humacyte Inc
  • McGill University
  • PetVivo Holdings Inc
  • Rox Medical Inc
  • MORE
Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2017" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Axcelon Biopolymers Corp.
  • Coromedic Ltd.
  • Humacyte Inc
  • McGill University
  • PetVivo Holdings Inc
  • Rox Medical Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Coronary Artery Bypass Graft Surgery Overview
3 Products under Development
3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
3.5 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
3.6 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies
4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
5 Coronary Artery Bypass Graft Surgery Companies and Product Overview
5.1 AdvanSource Biomaterials Corporation Company Overview
5.1.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Axcelon Biopolymers Corp. Company Overview
5.2.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.3 CardioPolymers Inc Company Overview
5.3.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardious, Inc. Company Overview
5.4.1 Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 CellProthera Company Overview
5.5.1 CellProthera Pipeline Products & Ongoing Clinical Trials Overview
5.6 Coromedic Ltd. Company Overview
5.6.1 Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Elana bv Company Overview
5.8.1 Elana bv Pipeline Products & Ongoing Clinical Trials Overview
5.9 Endogene Ltd Company Overview
5.9.1 Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Graft-Loc Inc. Company Overview
5.10.1 Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.11 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
5.11.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Humacyte Inc Company Overview
5.12.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 iiTech BV Company Overview
5.13.1 iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
5.14 LeMaitre Vascular Inc Company Overview
5.14.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Magenta Medical Inc Company Overview
5.15.1 Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 McGill University Company Overview
5.16.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
5.17 Miracor Medical Systems GmbH Company Overview
5.17.1 Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.18 Neograft Technologies Inc Company Overview
5.18.1 Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Nice University Hospital Company Overview
5.19.1 Nice University Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.20 NuVascular Technologies Inc Company Overview
5.20.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Palmaz Scientific Inc (Inactive) Company Overview
5.21.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.22 PetVivo Holdings Inc Company Overview
5.22.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Prekubator TTO Company Overview
5.23.1 Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview
5.24 RegenMedTX LLC Company Overview
5.24.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
5.25 Revivicor Inc Company Overview
5.25.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 Rox Medical Inc Company Overview
5.26.1 Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 SeamVad Ltd. Company Overview
5.27.1 SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.28 The University of Utah Company Overview
5.28.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.29 Thoratec Corp Company Overview
5.29.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview
5.30 Tissue Regeneration Technologies LLC Company Overview
5.30.1 Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 University College London Company Overview
5.31.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Arizona Company Overview
5.32.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
5.33 University of California Los Angeles Company Overview
5.33.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
6 Coronary Artery Bypass Graft Surgery- Recent Developments
6.1 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.2 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History
6.3 Aug 08, 2017: Dextera Surgical Reports Fiscal 2017 Fourth Quarter Financial Results
6.4 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results
6.5 Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
6.6 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
6.7 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.8 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results
6.9 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer
6.10 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
6.11 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.13 May 24, 2017: Fortimedix Surgical Strengthens U.S. Commercial Team with Appointment of David Castiglioni as Vice President of Sales in the United States
6.14 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
6.15 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results
6.16 May 04, 2017: Dextera Surgical Reports Fiscal 2017 Third Quarter Financial Results
6.17 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results
6.18 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
6.19 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.20 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%)
6.21 Apr 24, 2017: Dextera Surgical Announces Preliminary Fiscal 2017 Third Quarter Financial Highlights
6.22 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
6.23 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
6.24 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
6.25 Mar 06, 2017: AtriCure Announces hiring of Senior Vice President of Clinical, Regulatory, and Scientific Affairs
6.26 Mar 02, 2017: Sanofi’s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
6.27 Feb 28, 2017: AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results
6.28 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.29 Feb 21, 2017: Cardiovascular Systems Announces Healthcare Veteran Martha Goldberg Aronson Joins Board of Directors
6.30 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%)
6.31 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
6.32 Feb 07, 2017: Dextera Surgical Reports Fiscal 2017 Second Quarter Financial Results
6.33 Feb 06, 2017: Maquet Expands Patent Infringement Lawsuit Against Saphena Medical and Dr. Chin, Adds Claims for False Advertising and Correction of Patent Inventorship
6.34 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.35 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.36 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
6.37 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
6.38 Jan 25, 2017: Cardiovascular Systems Reports Fiscal 2017 Second-Quarter Financial Results
6.39 Jan 09, 2017: AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016
6.40 Dec 19, 2016: Maquet Files Suit against Saphena Medical, Inc. and Dr. Albert Chin to Protect its Intellectual Property
6.41 Dec 07, 2016: New governance at CellProthera
6.42 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.43 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.44 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.45 Nov 11, 2016: AtriCure Names Sven Wehrwein to its Board of Directors
6.46 Nov 07, 2016: Dextera Surgical Reports Fiscal 2017 First Quarter Financial Results
6.47 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results
6.48 Oct 27, 2016: AtriCure Reports Third Quarter 2016 Financial Results
6.49 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.50 Oct 26, 2016: Cardiovascular Systems Reports Fiscal 2017 First-Quarter Financial Results
6.51 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%)
6.52 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
6.53 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.54 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare
6.55 Sep 27, 2016: Hannu Syrjala Appointed as New Chairman for Medtentia’s Board of Directors
6.56 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
6.57 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation
6.58 Sep 06, 2016: Sanofi Board Of Directors Provides Update
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
Table 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
Table 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
Table 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
Table 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
Table 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
Table 7: Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
Table 8: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
Table 9: AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 10: CardioPass - Product Status
Table 11: CardioPass - Product Description
Table 12: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: BNC - PVA Based Vascular Graft - Product Status
Table 14: BNC - PVA Based Vascular Graft - Product Description
Table 15: CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Plexisyl-AF - Product Status
Table 17: Plexisyl-AF - Product Description
Table 18: Cardious, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: AvA Aortic Valve Bypass Graft System - Product Status
Table 20: AvA Aortic Valve Bypass Graft System - Product Description
Table 21: CellProthera Pipeline Products & Ongoing Clinical Trials Overview
Table 22: StemXpand Automated Device - Product Status
Table 23: StemXpand Automated Device - Product Description
Table 24: CellProthera - Ongoing Clinical Trials Overview
Table 25: StemXpand Automated Device - A Multicentric Controlled Phase I / IIb Study Evaluating the Safety and the Efficacy of in Vitro Expanded Peripheral Blood CD34+ Stem Cells Output by the StemXpand Automated Process, and Injected in Patients with an Acute Myocardial Infarction and a Left Ventricle Ejection Fraction (LVEF) Remaining Below or Equal to 45% after PTCA and Stent(s) Implantation Versus Standard of Care
Table 26: Coromedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Distal Anastomosis Device - Product Status
Table 28: Distal Anastomosis Device - Product Description
Table 29: Proximal Anastomosis Device - Product Status
Table 30: Proximal Anastomosis Device - Product Description
Table 31: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 32: LifeLine TEBV - CABG - Product Status
Table 33: LifeLine TEBV - CABG - Product Description
Table 34: Elana bv Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Artificial Vessel - Product Status
Table 36: Artificial Vessel - Product Description
Table 37: ELANA CLIP 3.0 - Product Status
Table 38: ELANA CLIP 3.0 - Product Description
Table 39: Endogene Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Linear Vascular Anastomosis System - Product Status
Table 41: Linear Vascular Anastomosis System - Product Description
Table 42: Graft-Loc Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Graft-Loc Device - Product Status
Table 44: Graft-Loc Device - Product Description
Table 45: H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Vascular Stent - Product Status
Table 47: Vascular Stent - Product Description
Table 48: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 49: HAV Graft - CABG - Product Status
Table 50: HAV Graft - CABG - Product Description
Table 51: iiTech BV Pipeline Products & Ongoing Clinical Trials Overview
Table 52: S² Distal Anastomotic System - Product Status
Table 53: S² Distal Anastomotic System - Product Description
Table 54: S² Proximal Anastomotic System - Product Status
Table 55: S² Proximal Anastomotic System - Product Description
Table 56: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Elongated AnastoClip GC - Product Status
Table 58: Elongated AnastoClip GC - Product Description
Table 59: Magenta Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Magenta Device - Congestive Heart Failure - Product Status
Table 61: Magenta Device - Congestive Heart Failure - Product Description
Table 62: McGill University Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Transcatheter Aorta Pulmonary Shunt - Product Status
Table 64: Transcatheter Aorta Pulmonary Shunt - Product Description
Table 65: Miracor Medical Systems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 66: PiCSOAMI Impulse Console - CABG - Product Status
Table 67: PiCSOAMI Impulse Console - CABG - Product Description
Table 68: Miracor Medical Systems GmbH - Ongoing Clinical Trials Overview
Table 69: PiCSOAMI Impulse Console - CABG - Pressure Controlled Intermittent Coronary Sinus Occlusion as an Adjunct to PCI in Acute Coronary Syndrome. (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to pPCI in Patients with Anterior NSTEMI or Following pPCI in STEMI) (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to PPCI in Patients with Anterior NSTEMI or Following pPCI in STEMI)
Table 70: Neograft Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Angioshield - Product Status
Table 72: Angioshield - Product Description
Table 73: Neograft Technologies Inc - Ongoing Clinical Trials Overview
Table 74: Angioshield - Feasibility Study to Demonstrate the Safety of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery: THE ANGIOSHIELD STUDY
Table 75: Nice University Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Shark Anastomosis Connector - Product Status
Table 77: Shark Anastomosis Connector - Product Description
Table 78: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 79: BioFunc - APC Vascular Graft - Product Status
Table 80: BioFunc - APC Vascular Graft - Product Description
Table 81: Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 82: SESAME Stent - Product Status
Table 83: SESAME Stent - Product Description
Table 84: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Coronary Artery Bypass Graft - Product Status
Table 86: Coronary Artery Bypass Graft - Product Description
Table 87: Prekubator TTO Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Snapcon - Product Status
Table 89: Snapcon - Product Description
Table 90: RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Neo-Vessel Replacement - Coronary Artery Bypass - Product Status
Table 92: Neo-Vessel Replacement - Coronary Artery Bypass - Product Description
Table 93: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Blood Vessel - Product Status
Table 95: Blood Vessel - Product Description
Table 96: Rox Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 97: ROX Anastomotic Coupler System - Product Status
Table 98: ROX Anastomotic Coupler System - Product Description
Table 99: SeamVad Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 100: MySide - Product Status
Table 101: MySide - Product Description
Table 102: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Automated Arterial Anastomotic Device - Product Status
Table 104: Automated Arterial Anastomotic Device - Product Description
Table 105: Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Automated Anastomosis Device - Product Status
Table 107: Automated Anastomosis Device - Product Description
Table 108: Tissue Regeneration Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Cardiogold - Product Status
Table 110: Cardiogold - Product Description
Table 111: University College London Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Small Diameter Conduit - Product Status
Table 113: Small Diameter Conduit - Product Description
Table 114: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Vascular Anastomosis Device - Product Status
Table 116: Vascular Anastomosis Device - Product Description
Table 117: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Sutureless Anastomosis Device - Product Status
Table 119: Sutureless Anastomosis Device - Product Description
Table 120: Glossary

List of Figures
Figure 1: Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
Figure 2: Coronary Artery Bypass Graft Surgery - Pipeline Products by Segment
Figure 3: Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
Figure 4: Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
Figure 5: Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
Figure 6: Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AdvanSource Biomaterials Corporation
  • Axcelon Biopolymers Corp.
  • CardioPolymers Inc
  • Cardious, Inc.
  • CellProthera
  • Coromedic Ltd.
  • Cytograft Tissue Engineering Inc
  • Elana bv
  • Endogene Ltd
  • Graft-Loc Inc.
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Humacyte Inc
  • iiTech BV
  • LeMaitre Vascular Inc
  • Magenta Medical Inc
  • McGill University
  • Miracor Medical Systems GmbH
  • Neograft Technologies Inc
  • Nice University Hospital
  • NuVascular Technologies Inc
  • Palmaz Scientific Inc
  • PetVivo Holdings Inc
  • Prekubator TTO
  • RegenMedTX LLC
  • Revivicor Inc
  • Rox Medical Inc
  • SeamVad Ltd.
  • The University of Utah
  • Thoratec Corp
  • Tissue Regeneration Technologies LLC
  • University College London
  • University of Arizona
  • University of California Los Angeles
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll